AIDS Treatment News logo      

July 19, 2009

Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations

"Conclusions: Dose reduction may prevent toxicity-induced discontinuations in patients with high efavirenz plasma concentrations, whereas not compromising virological efficacy."

Read more in JAIDS, July 10, 2009.

0 comments: